|1||NCT02380521||Completed||Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes||
||Other / Industry||
||60||All||18 Years to 80 Years (Adult, Senior)||NCT02380521||ESR-14-10139||January 2015||July 2016||November 2016||March 5, 2015||November 8, 2016||
|A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)||
||514||All||18 Years and older (Adult, Senior)||NCT00637273||BCB106 (DURATION - 2)||January 2008||February 2009||July 2009||March 17, 2008||April 7, 2015||June 19, 2012||
† Study has passed its completion date and status has not been verified in more than two years.